USFDA inspects Indoco Remedies’ manufacturing facilities in Goa

27 Jul 2024 Evaluate

United States Food and Drug Administration (USFDA) has inspected Indoco Remedies’ manufacturing facilities at Plant II (Sterile) and Plant III located at Goa (Facility) from July 16, 2024 to July 26, 2024. On conclusion of the inspection, the company received 7 observations in Form 483. The company is addressing the observations comprehensively and will respond to the USFDA within the stipulated timeframe.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.


Indoco Remedies Share Price

214.95 8.00 (3.87%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×